DanioLabs Overview

  • Founded
  • 2001
  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • M&A
  • Latest Deal Amount
  • $29.2M
Latest Deal Amount

DanioLabs General Information


Operator of a therapeutics discovery company in the fields of neurology and ophthalmology. The company has two primary business streams, phenotypic evaluation of compounds for other organizations, either for activity effects, or for pre-clinical safety pharmacology and internal research and development investigating new uses for established drugs (Reprofiling).

Contact Information

Ownership Status
Financing Status
Formerly VC-backed
Primary Industry
Other Industries
Drug Discovery
Primary Office
  • 7330 Cambridge Research Park
  • Cambridge CB5 9TN
  • England, United Kingdom
+44 01223 000000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

DanioLabs Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Merger/Acquisition 21-Mar-2007 $29.2M 000.00 000.00 Completed Product Development
5. Early Stage VC 17-Jan-2005 00.000 000.00 Completed Product Development
4. Early Stage VC 18-May-2004 000 000 Completed Product Development
3. Grant 18-May-2004 00000 000 Completed Product Development
2. Early Stage VC 06-Nov-2002 $710K $2M Completed Product Development
1. Seed Round 10-Jul-2002 $1.29M $1.29M Completed Startup
To view DanioLabs’s complete valuation and funding history, request access »

DanioLabs Executive Team (3)

Name Title Board Seat Contact Info
Bill Harris Co-Founder
Herwig Baier Co-Founder
You’re viewing 2 of 3 executive team members. Get the full list »

DanioLabs Former Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Cambridge Angels Angel Group Minority 000 0000 000000 0
Cambridge Gateway Fund Venture Capital Minority 000 0000 000000 0
GEIF Ventures Venture Capital Minority 000 0000 000000 0
Merifin Capital Venture Capital Minority 000 0000 000000 0
NVM Private Equity PE/Buyout Minority 000 0000 000000 0
You’re viewing 5 of 7 investors. Get the full list »